A novel HLA-C allele, HLA-C*08:128, was identified in a leukemia patient by polymerase chain reaction sequence-based

W Zhang1,2,3, S-D Tao1,2,3, Z-D Han1,2,3

  • 1HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.

HLA
|February 7, 2017
PubMed

Insights

The human leukocyte antigen (HLA) -C*08:128 allele differs from HLA-C*08:01:01 by a single nucleotide polymorphism at position 704. This finding contributes to understanding HLA allele diversity.

Area of Science:

  • Immunogenetics
  • Molecular biology

Background:

  • The human leukocyte antigen (HLA) system is crucial for immune response.
  • Specific HLA alleles are associated with various diseases and drug reactions.
  • Detailed characterization of novel HLA alleles is essential for understanding immune system variations.

Purpose of the Study:

  • To describe the molecular differences between the novel HLA-C*08:128 allele and a known reference allele.

Main Methods:

  • Sequence analysis of the HLA-C gene.
  • Comparison of nucleotide sequences between HLA-C*08:128 and HLA-C*08:01:01.

Main Results:

  • A single nucleotide substitution (C to T) was identified at position 704 in HLA-C*08:128 compared to HLA-C*08:01:01.
  • This substitution results in a distinct genetic profile for the HLA-C*08:128 allele.

Conclusions:

  • HLA-C*08:128 represents a newly identified variant within the HLA-C locus.
  • This molecular characterization adds to the known repertoire of HLA alleles.

Related Concept Videos